Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreGet the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.
Read The Latest Issue"Unlocking the Future of Consumer Health: A Special Focus on Senior Consumers
Learn MoreImproving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
Search JobsIQVIA brings together exceptional expertise in Cell and Gene Therapy (CAGT) across the Cell and Gene Therapy development lifecycle, to help you increase the efficiency of your program and maximize the value of new therapies.
IQVIA established the Cell and Gene Therapy Center of Excellence in 2019 to develop patient-centered, data driven, hand-tailored strategies for CAGT trials. With the ultimate goal of getting new treatments to patients faster.
Leveraging in-depth therapeutic expertise and operational leadership, IQVIA is prepared to be your CRO partner - providing end-to-end expertise and services, tailored to the needs of CAGT drug development.
Emerging biopharma companies are at the forefront of advanced therapies that are bringing hope to millions. As the CAGT space continues to grow, there are unique opportunities and challenges.
The APAC CAGT landscape, often perceived as uncertain is primed for clinical research and market access success
Insights specific to cell and gene therapy markets
Leveraging virtual approaches and real world data